issue

Nov 18, 2022

Volume 18 Number 10

This is the dedicated PCR London Valves edition with debates on key issues in the management of valvular disease and articles on the critical role played by evaluating coronary artery disease (CAD) in predicting unplanned percutaneous coronary interventions (PCI) after transcatheter aortic valve replacement (TAVR); TAVR and the incidence of paravalvular aortic regurgitation (AR) using the new ACURATE neo2; comparing percutaneous vascular closure strategies after TAVI using either Dual ProGlide vs ProGlide and FemoSeal, a combination of suture-based with plug-based vascular closure devices approach; the management of deteriorated mitral bioprostheses using either transcatheter valve-in-valve implantation or redo surgical mitral valve replacement; a new surgical procedure for extracardiac annuloplasty using the BACE (Basal Annuloplasty of the Cardia Externally) device; using historic data from surgical tricuspid valve replacement (TVR) studies as a benchmark for the development of tricuspid valve replacement (TTVR) trials; the impact of RV-pulmonary artery (PA) coupling on clinical outcomes of tricuspid regurgitation in patients undergoing mitral transcatheter edge-to-edge repair (TEER); first in human use of the Topaz transcatheter tricuspid valve replacement device; and more...

Viewpoint

In search of the origin of the acronym TAVI
Gaspard PE
10.4244/EIJ-D-22-00636
free

Debate

PCI of bystander coronary artery lesions should be performed before TAVI: pros and cons
Amat-Santos I, Blasco-Turrión S, Ferrero V, Ribichini F
10.4244/EIJ-E-22-00038
free
TAVI in moderate aortic stenosis and heart failure: pros and cons
Delgado V, Manca P, Senni M
10.4244/EIJ-E-22-00039
free
TAVI in younger patients with bicuspid aortic stenosis: pros and cons
Blackman D, Ali N, Borger MA
10.4244/EIJ-E-22-00042
free

Interventions for valvular disease and heart failure

Long-term risk of unplanned percutaneous coronary intervention after transcatheter aortic valve replacement
Okuno T, Demirel C, Tomii D, Heg D, Häner JD, Siontis G, Lanz J, Räber L, Strotecky S, Fürholz M, Praz F, Windecker S, Pilgrim T
10.4244/EIJ-D-22-00342
free
Haemodynamic performance and clinical outcomes of transcatheter aortic valve replacement with the self-expanding ACURATE neo2
Scotti A, Pagnesi M, Kim W, Schäfer U, Barbanti M, Costa G, Baggio S, Casenghi M, De Marco F, Vanhaverbeke M, Søndergaard L, Wolf A, Schofer J, Ancona M, Montorfano M, Kornowski R, Vaknin-Assa H, Toggweiler S, Ielasi A, Hildick-Smith D, Windecker S, Schmidt A, Buono A, Maffeo D, Siqueira D, Giannini F, Adamo M, Massussi M, Wood DA, Sinning J, Van der Heyden J, van Ginkel DJ, Van Mieghem N, Veulemans V, Mylotte D, Tzalamouras V, Taramasso M, Estevez-Loureiro R, Colombo A, Mangieri A, Latib A
10.4244/EIJ-D-22-00289
free
Dual ProGlide versus ProGlide and FemoSeal for vascular access haemostasis after transcatheter aortic valve implantation
Gmeiner J, Linnemann M, Steffen J, Scherer C, Orban M, Theiss H, Mehilli J, Sadoni S, Peterß S, Joskowiak D, Hagl C, Tsilimparis N, Curta A, Maurus S, Doldi P, Löw K, Haum M, Roden D, Hausleiter J, Massberg S, Rizas K, Deseive S, Braun D
10.4244/EIJ-D-22-00311
free
Coronary access techniques following ACURATE neo2 implantation in surgical bioprosthesis
Khokhar A, Ponticelli F, Zlahoda-Huzior A, Zakrzewski P, Mikhail G, Dudek D, Giannini F
10.4244/EIJ-D-22-00149
free
Commissural alignment with the novel Hydra transcatheter heart valve during aortic valve replacement
Buono A, Messina A, Bettari L, Pero G, Cuccia C, Ielasi A, Bieliauskas G, Maffeo D
10.4244/EIJ-D-22-00173
free
Transcatheter valve-in-valve implantation versus redo surgical mitral valve replacement in patients with failed mitral bioprostheses
Zahid S, Ullah W, Hashem A, Khan M, Gowda S, Vishnevsky A, Fischman D
10.4244/EIJ-D-22-00437
free
Extracardiac basal annuloplasty for the treatment of secondary mitral regurgitation
Bernard J, Salaun E, Padmanabhan C, Deja M, Hote M, Choudhary S, Hlavička J, Saldanha R, Brát R, Jain A, Shastri N, Bhat S, NC C, Durairaj M, Das B, Agarwal A, Rao V, Talluri K, Beaudoin J, Bernier M, Côté N, Raman J, Pibarot P
10.4244/EIJ-D-22-00363
free
Outcomes of isolated tricuspid valve replacement: a systematic review and meta-analysis of 5,316 patients from 35 studies
Scotti A, Sturla M, Granada JF, Kodali SK, Coisne A, Mangieri A, Godino C, Ho E, Goldberg Y, Chau M, Jorde UP, Garcia M, Maisano F, Bapat VN, Ailawadi G, Latib A
10.4244/EIJ-D-22-00442
free
Impact of right ventricular-pulmonary arterial coupling on clinical outcomes of tricuspid regurgitation
Sugiura A, Kavsur R, Spieker M, Iliadis C, Mauri V, Tanaka T, Goto T, Weber M, Kelm M, Baldus S, Nickenig G, Westenfeld R, Pfister R, Becher M
10.4244/EIJ-D-22-00045
free
First-in-human implantation of the Topaz transcatheter tricuspid valve replacement system
Teiger E, Nejjari M, Lim P, Ruf T, Blanke P, Schäfer U, Treede H, Gallet R, Dreyfus J
10.4244/EIJ-D-22-00277
free

Receive our newsletter

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 6.2
2022 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2023)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2024 Europa Group - All rights reserved